Associations between circadian disruption and cardiometabolic disease risk: A review.
Velarie Ansu BaidooKristen L KnutsonPublished in: Obesity (Silver Spring, Md.) (2023)
The human circadian system plays a vital role in many physiological processes, and circadian rhythms are found in virtually all tissues and organs. The disruption of circadian rhythms may lead to adverse health outcomes. Evidence from recent population-based studies was reviewed because they represent real-world behavior and can be useful in developing future studies to reduce the risk of adverse health conditions, including cardiovascular diseases, obesity, and diabetes mellitus, which may occur because of circadian disruption. An electronic search in PubMed and Web of Science (2012-2022) was performed. Selected articles were based on specific inclusion and exclusion criteria. Five factors that may disrupt circadian rhythm alignment are discussed: shift work, late chronotype, late sleep timing, sleep irregularity, and late meal timing. Evidence from observational studies of these circadian disruptors suggests potential detrimental effects on cardiometabolic health, including higher BMI/obesity, higher blood pressure, greater dyslipidemia, greater inflammation, and diabetes. Future research should identify the specific underlying pathways in order to mitigate the health consequences of shift work. Furthermore, optimal sleep and mealtimes for metabolic health can be explored in intervention studies. Lastly, it is important that the timing of external environmental cues (such as light) and behaviors that influence circadian rhythms are managed.
Keyphrases
- public health
- healthcare
- blood pressure
- mental health
- cardiovascular disease
- type diabetes
- health information
- insulin resistance
- metabolic syndrome
- randomized controlled trial
- physical activity
- gene expression
- weight loss
- oxidative stress
- emergency department
- weight gain
- body mass index
- case control
- atrial fibrillation
- health promotion
- heart rate
- depressive symptoms
- risk assessment
- adipose tissue
- coronary artery disease
- skeletal muscle
- glycemic control
- cardiovascular events
- cardiovascular risk factors
- adverse drug